• 506 enterococcal phage and prophage genomes were scanned for tail module lysins. • Identified lysins target cell wall, teichoic acids and enterococcal polysaccharide antigen. • Most common identified lysin was endopeptidase in both phage and prophage genomes. • Lytic transglycosylase lysins possess unique motifs and locate in tape measure proteins. • This study provides a rich foundation for phage engineering and TAL recombinant expression.

Enterococci are robust Gram-positive bacteria that pose a significant threat in healthcare settings due to antibiotic resistance, with vancomycin-resistant enterococci (VRE) most prominent. To tackle this issue, bacteriophages (bacterial viruses) can be exploited as they specifically and efficiently target bacteria. Here, we successfully isolated and characterised a set of novel phages: SHEF10, SHEF11, SHEF13, SHEF14, and SHEF16 which target E. faecalis (SHEF10,11,13), or E. faecium (SHEF13, SHEF14 & SHEF16) strains including a range of clinical and VRE isolates. Genomic analysis shows that all phages are strictly lytic and diverse in terms of genome size and content, quickly and effectively lysing strains at different multiplicity of infections. Detailed analysis of the broad host-range SHEF13 phage revealed the crucial role of the enterococcal polysaccharide antigen (EPA) variable region in its infection of E. faecalis V583. In parallel, the discovery of a carbohydrate-targeting domain (CBM22) found conserved within the three phage genomes indicates a role in cell surface interactions that may be important in phage-bacterial interactons. These findings advance our comprehension of phage-host interactions and pave the way for targeted therapeutic strategies against antibiotic-resistant enterococcal infections.

The worldwide antimicrobial resistance (AMR) threat continues to grow, causing an estimate of 4.71 million deaths during 2021. Scientists predict it could lead to 10 million deaths each year by 2050 unless effective solutions are developed. The government of Saudi Arabia implemented the AMR Action Plan (2022–2025) and participated in the 4th Global High-Level Ministerial Conference on AMR (2024) to address this issue. However, ESBL-producing Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii remain major threats in Saudi Arabia. Bacteriophage therapy offers a promising additional treatment approach as phages specifically attack bacteria. They also evolve and demonstrate effectiveness against bacteria that form biofilms. This review evaluates Saudi Arabia’s readiness for phage-based therapy implementation through an analysis of both local and worldwide antibiotic resistance data.

Microbial synthesis of selenium nanoparticles (SeNPs) offers a sustainable alternative to chemical routes, but the genetic basis of selenium handling in Bacillus remains poorly defined, which limits rational strain selection. Here, SeNP production, physicochemical characterization, and closed-genome sequencing are combined for Bacillus licheniformis BLN313. Selenite reduction peaked at 500 µg/mL Na₂SeO₃ (88.8% conversion; 444 ± 27 µg/mL Se⁰); at higher concentrations, conversion efficiency and viability diverged, indicating that tolerance and reductive capacity are distinct traits. Purified SeNPs were spherical and partially crystalline trigonal Se⁰ (TEM 190 ± 52 nm; DLS 166 nm, PDI 0.03; zeta potential −20.8 mV), carrying a proteinaceous capping layer confirmed by XPS, EDS, and FTIR and shown by LC-MS to be enriched in cell wall-derived metabolites. The particles were bactericidal against Micrococcus luteus (MIC 62.5 µg/mL) and Klebsiella pneumoniae (MIC 250 µg/mL) and reduced MCF-7 viability (IC50 2.7 µg/mL) while sparing MCF-10A cells. The 4.11 Mb genome (46.3% GC; ANI 99.7%, dDDH 97.8%) encodes SulP and Pit transporters, multiple trxB copies, and sulfur-metabolism and oxidative-stress genes, defining a candidate gene set for selenium uptake, reduction and detoxification. BLN313 thus provides a genetically defined platform for SeNP production in biomedical and environmental applications.

The red imported fire ant (RIFA), Solenopsis invicta, is a globally invasive pest that causes substantial ecological, agricultural, and public health challenges. Conventional control strategies primarily depend on chemical insecticides, which present environmental risks and limited long-term efficacy. In this study, we comprehensively investigated the bacterial microbiota of S. invicta and compared it with a sympatric non-target ant species (Pheidole nodus) to explore the ecological significance and biocontrol potential of symbiotic bacteria. High-throughput 16S rRNA sequencing revealed that the symbiotic bacterial community of S. invicta exhibited markedly higher richness and diversity. A total of 1651 amplified sequence variants (ASVs) were identified, of which 1089 ASVs are unique to the RIFAs, and 460 are unique to non-target ants. Linear discriminant analysis effect size (LEfSe) highlighted 33 biomarker taxa (score > 6.5), with strong enrichment of Stenotrophomonas, Serratia, Pseudomonas, Luteibacter, Bradyrhizobium, Brucella, Smaragdicoccus, Gordonia, and Aeromonas. Functional predictions and enzymatic assays in vitro demonstrated that dominant cultivable genera, particularly Stenotrophomonas (SI-7, SI-17), Serratia (SI-1, SI-3, SI-6, SI-18), and Pseudomonas (SI-2, SI-8, SI-9, SI-11, SI-19), exhibit substantial proteolytic and lipolytic activity, suggesting key roles in nutrient metabolism and host ecological adaptability. Antibiotic susceptibility profiling further revealed that florfenicol shows broad-spectrum inhibitory activity against these dominant symbionts. These findings indicate that disrupting dominant symbiotic bacteria may impair host physiology and thus serve as a targeted control strategy. Overall, the study elucidates the diversity, functional potential, and biocontrol applicability of the S. invicta microbiome, providing a foundation for developing sustainable, microbiome-based pest management approaches.